Exploring The Current Management Idiopathic Intracranial Hypertension, And Understanding The Role Of Dural Venous Sinus Stenting

References

• Mollan SP, Ali F, Hassan-Smith G, et al. Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management. J Neurol Neurosurg Psychiatry. 2016;87(9):982–992. doi:10.1136/jnnp-2015-31130226888960
   PubMed Web of Science ®Google Scholar
• Friedman DI, Liu GT, Digre KB. Revised diagnostic criteria for the pseudotumor cerebri syndrome in adults and children. Neurology. 2013;81:1159–1165. doi:10.1212/WNL.0b013e3182a55f1723966248
   PubMed Web of Science ®Google Scholar
• Raoof N, Sharrack B, Pepper IM, Hickman SJ. The incidence and prevalence of idiopathic intracranial hypertension in Sheffield, UK. Eur J Neurol. 2011;18:1266–1268. doi:10.1111/ene.2011.18.issue-1021426442
   PubMed Web of Science ®Google Scholar
• Mollan SP, Aguiar M, Evison F, et al. The expanding burden of idiopathic intracranial hypertension. Eye. 2018;81:1159.
   Google Scholar
• Markey KA, Mollan SP, Jensen RH, Sinclair AJ. Understanding idiopathic intracranial hypertension: mechanisms, management, and future directions. Lancet Neurol. 2016;15(1):78–79. doi:10.1016/S1474-4422(15)00298-726700907
   PubMed Web of Science ®Google Scholar
• Hornby C, Botfield H, O’Reilly MW, et al. Evaluating the fat distribution in idiopathic intracranial hypertension using dual-energy X-ray absorptiometry scanning. Neuroophthalmology. 2017;42(2):99–104. doi:10.1080/01658107.2017.133421829563954
   PubMed Web of Science ®Google Scholar
• Hornby C, Mollan SP, Botfield H, et al. Metabolic concepts in idiopathic intracranial hypertension and their potential for therapeutic intervention. J Neuroophthalmol. 2018;38(4):522–530. doi:10.1097/WNO.000000000000068429985799
   PubMed Web of Science ®Google Scholar
• O’Reilly MW, Westgate CS, Hornby C, et al. A unique androgen excess signature in idiopathic intracranial hypertension is linked to cerebrospinal fluid dynamics. JCI Insight. 2019;4(6):125348. doi:10.1172/jci.insight.12268630753168
   PubMed Web of Science ®Google Scholar
• Adderley NJ, Subramanian A, Nirantharakumar K, et al. Association between idiopathic intracranial hypertension and risk of cardiovascular diseases in women in the United Kingdom. JAMA Neurol. 2019;8:e191812.
   Google Scholar
• Mollan SP, Spitzer D, Nicholl DJ. Raised intracranial pressure in those presenting with headache. BMJ. 2018;363:k3252. doi:10.1136/bmj.k325230287521
   PubMed Web of Science ®Google Scholar
• Mollan SP, Hoffman J, Sinclair AJ. Advances in the understanding of headache in idiopathic intracranial hypertension. Curr Opin Neurol. 2019;32(1):92–98. doi:10.1097/WCO.000000000000065130547900
   PubMed Web of Science ®Google Scholar
• Mollan SP, Markey KA, Benzimra JD, et al. A practical approach to, diagnosis, assessment and management of idiopathic intracranial hypertension. Pract Neurol. 2014;14(6):380–390. doi:10.1136/practneurol-2014-00082124809339
   PubMedGoogle Scholar
• Corbett JJ, Savino PJ, Thompson HS, et al. Visual loss in pseudotumor cerebri. Follow-up of 57 patients from five to 41 years and a profile of 14 patients with permanent severe visual loss. Arch Neurol. 1982;39:461–474. doi:10.1001/archneur.1982.005102000030017103794
   PubMedGoogle Scholar
• Mulla Y, Markey KA, Woolley RL, et al. Headache determines quality of life in idiopathic intracranial hypertension. J Headache Pain. 2015;16:521. doi:10.1186/s10194-015-0521-925982204
   PubMed Web of Science ®Google Scholar
• Scotton WJ, Mollan SP, Walters T, et al. Characterising the patient experience of diagnostic lumbar puncture in idiopathic intracranial hypertension: a cross-sectional online survey. BMJ Open. 2018;8(5):e020445. doi:10.1136/bmjopen-2017-020445
   PubMed Web of Science ®Google Scholar
• Mollan SP, Davies B, Silver NC, et al. Idiopathic intracranial hypertension: consensus guidelines on management. J Neurol Neurosurg Psychiatry. 2018;89(10):1088–1100. doi:10.1136/jnnp-2017-31744029903905
   PubMed Web of Science ®Google Scholar
• Mollan SP, Hemmings K, Herd C, et al. What are the research priorities for idiopathic intracranial hypertension? A priority setting partnership between patients and health care professionals. BMJ Open. 2019;9(3):e026573. doi:10.1136/bmjopen-2018-026573
   PubMed Web of Science ®Google Scholar
• Piper R, Kalyvas AV, Young AMH, et al. Interventions for idiopathic intracranial hypertension. Cochrane Database Syst Rev. 2015;8:CD003434.
   Google Scholar
• Ball AK, Howman A, Wheatley K, et al. A randomised controlled trial of treatment for idiopathic intracranial hypertension. J Neuro.l. 2011;258:874–881. doi:10.1007/s00415-010-5861-4
   PubMed Web of Science ®Google Scholar
• Wall M, McDermott MP, Kieburtz KD, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension: the idiopathic intracranial hypertension treatment trial. JAMA. 2014;311:1641–1651. doi:10.1001/jama.2014.331224756514
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Burdon MA, Nightingale PG, et al. Low energy diet and intracranial pressure in women with idiopathic intracranial hypertension: prospective cohort study. BMJ. 2010;341:c2701–c2701. doi:10.1136/bmj.c270120610512
   PubMed Web of Science ®Google Scholar
• Ottridge R, Mollan SP, Botfield H, et al. Randomised controlled trial of bariatric surgery versus a community weight loss programme for the sustained treatment of idiopathic intracranial hypertension: the Idiopathic Intracranial Hypertension Weight Trial (IIH:WT) protocol. BMJ Open. 2017;7(9):e017426. doi:10.1136/bmjopen-2017-017426
   PubMed Web of Science ®Google Scholar
• Çelebisoy N, Gökçay F, Şirin H, Akyürekli Ö. Treatment of idiopathic intracranial hypertension: topiramate vs acetazolamide, an open-label study. Acta Neurol Scand. 2007;116(5):322–327. doi:10.1111/ane.2007.116.issue-517922725
   PubMed Web of Science ®Google Scholar
• Scotton WJ, Botfield HF, Westgate CS, et al. Topiramate is more effective than acetazolamide at lowering intracranial pressure. Cephalalgia. 2019;39(2):209–218. doi:10.1177/033310241877645529898611
   PubMed Web of Science ®Google Scholar
• Markey K, Mitchell J, Botfield H, et al. 11β-hydroxysteroid dehydrogenase type 1 inhibition in idiopathic intracranial hypertension: a double-blind randomized controlled trial. Brain Commun. 2019. in progress.
   Google Scholar
• Hoffmann J, Mollan SP, Paemeleire K, et al. European headache federation guideline on idiopathic intracranial hypertension. J Headache Pain. 2018;19(1):93. doi:10.1186/s10194-018-0919-230298346
   PubMed Web of Science ®Google Scholar
• Sinclair AJ, Kuruvath S, Sen D, et al. Is cerebrospinal fluid shunting in idiopathic intracranial hypertension worthwhile? A 10-year review. Cephalalgia. 2011;31:1627–1633. doi:10.1177/033310241142330521968519
   PubMed Web of Science ®Google Scholar
• Kalyvas AV, Hughes M, Koutsarnakis C, et al. Efficacy, complications and cost of surgical interventions for idiopathic intracranial hypertension: a systematic review of the literature. Acta Neurochir (Wien.). 2017;159(1):33–49. doi:10.1007/s00701-016-3010-227830325
   PubMed Web of Science ®Google Scholar
• Gilbert AL, Chwalisz B, Mallery R. Complications of optic nerve sheath fenestration as a treatment for idiopathic intracranial hypertension. Semin Ophthalmol Y. 2018;33(1):36–41. doi:10.1080/08820538.2017.1353810
   PubMed Web of Science ®Google Scholar
• Higgins JN, Owler BK, Cousins C, et al. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359:228–230. doi:10.1016/S0140-6736(02)07440-811812561
   PubMed Web of Science ®Google Scholar
• Owler BK, Parker G, Halmagyi GM, et al. Pseudotumor cerebri syndrome: venous sinus obstruction and its treatment with stent placement. J Neurosurg. 2003;98(5):1045–1055. doi:10.3171/jns.2003.98.5.104512744365
   PubMed Web of Science ®Google Scholar
• Donnet A, Metellus P, Levrier O, et al. Endovascular treatment of idiopathic intracranial hypertension: clinical and radiologic outcome of 10 consecutive patients. Neurology. 2008;70:641–647. doi:10.1212/01.wnl.0000299894.30700.d218285539
   PubMed Web of Science ®Google Scholar
• Bussière M, Falero R, Nicolle D, et al. Unilateral transverse sinus stenting of patients with idiopathic intracranial hypertension. Am J Neuroradiol. 2010;31:645–650. doi:10.3174/ajnr.A189019942702
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Wilkinson M, Parker GD, et al. Transverse sinus stenting for idiopathic intracranial hypertension: a review of 52 patients and of model predictions. Am J Neuroradiol. 2011;32:1408–1414. doi:10.3174/ajnr.A257521799038
   PubMed Web of Science ®Google Scholar
• Albuquerque FC, Dashti SR, Hu YC, et al. Intracranial venous sinus stenting for benign intracranial hypertension: clinical indications, technique, and preliminary results. World Neurosurg. 2011;75:648–652. doi:10.1016/j.wneu.2010.11.01221704931
   PubMed Web of Science ®Google Scholar
• Lazzaro MA, Darkhabani Z, Remler BF, et al. Venous sinus pulsatility and the potential role of dural incompetence in idiopathic intracranial hypertension. Neurosurgery. 2012;71(4):877–884. doi:10.1227/NEU.0b013e318267a8f922989961
   PubMed Web of Science ®Google Scholar
• He C-ZC, Ji X-MX, Wang L-JL, et al. Endovascular treatment for venous sinus stenosis in idiopathic intracranial hypertension. Zhonghua Yi Xue Za Zhi. 2012;92(11):748–751.22781354
   PubMedGoogle Scholar
• Kumpe DA, Bennett JL, Seinfeld J, et al. Dural sinus stent placement for idiopathic intracranial hypertension. J Neurosurg. 2012;116:538–548. doi:10.3171/2011.10.JNS10141022149379
   PubMed Web of Science ®Google Scholar
• Radvany MG, Solomon D, Nijjar S, et al. Visual and neurological outcomes following endovascular stenting for pseudotumor cerebri associated with transverse sinus stenosis. J Neuroophthalmol. 2013;33:117–122. doi:10.1097/WNO.0b013e31827f18eb23502837
   PubMed Web of Science ®Google Scholar
• Fields JD, Javedani PP, Falardeau J, et al. Dural venous sinus angioplasty and stenting for the treatment of idiopathic intracranial hypertension. J Neurointerv Surg. 2013;5:62–68. doi:10.1136/neurintsurg-2011-01015622146571
   PubMed Web of Science ®Google Scholar
• Ducruet AF, Crowley RW, McDougall CG, Albuquerque FC. Long-term patency of venous sinus stents for idiopathic intracranial hypertension. J Neurointerv Surg. 2014;6:238–242. doi:10.1136/neurintsurg-2013-01069123585640
   PubMed Web of Science ®Google Scholar
• Teleb MS, Cziep ME, Issa M, et al. Stenting and angioplasty for idiopathic intracranial hypertension: a case series with clinical, angiographic, ophthalmological, complication, and pressure reporting. J Neuroimaging. 2015;25:72–80. doi:10.1111/jon.2015.25.issue-125729814
   PubMed Web of Science ®Google Scholar
• Aguilar-Perez M, Martinez-Moreno R, Kurre W, et al. Endovascular treatment of idiopathic intracranial hypertension: retrospective analysis of immediate and long-term results in 51 patients. Neuroradiology. 2017;59:277–287. doi:10.1007/s00234-017-1783-528255904
   PubMed Web of Science ®Google Scholar
• Liu KC, Starke RM, Durst CR, et al. Venous sinus stenting for reduction of intracranial pressure in IIH: a prospective pilot study. J Neurosurg. 2017;127:1126–1133. doi:10.3171/2016.8.JNS1687928009240
   PubMed Web of Science ®Google Scholar
• Satti SR, Leishangthem L, Spiotta A, Chaudry MI. Dural venous sinus stenting for medically and surgically refractory idiopathic intracranial hypertension. Interv Neuroradiol. 2017;23:186–193. doi:10.1177/159101991668011028304207
   PubMed Web of Science ®Google Scholar
• Dinkin MJ, Patsalides A. Venous sinus stenting in idiopathic intracranial hypertension: results of a prospective trial. J Neuroophthalmol. 2017;37(2):113–121. doi:10.1097/WNO.000000000000042627556959
   PubMed Web of Science ®Google Scholar
• Cappuzzo JM, Hess RM, Morrison JF, et al. Transverse venous stenting for the treatment of idiopathic intracranial hypertension, or pseudotumor cerebri. Neurosurg Focus. 2018;45(1):E11. doi:10.3171/2018.5.FOCUS18102
   PubMed Web of Science ®Google Scholar
• Asif H, Craven CL, Siddiqui AH, et al. Idiopathic intracranial hypertension: 120-day clinical, radiological, and manometric outcomes after stent insertion into the dural venous sinus. J Neurosurg. 2018;129:723–731. doi:10.3171/2017.4.JNS16287128984521
   PubMed Web of Science ®Google Scholar
• Shields LBE, Shields CB, Yao TL, et al. Endovascular treatment for venous sinus stenosis in idiopathic intracranial hypertension: an observational study of clinical indications, surgical technique, and long-term outcomes. World Neurosurg. 2019;121:e165–e171. doi:10.1016/j.wneu.2018.09.07030248468
   PubMed Web of Science ®Google Scholar
• Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003;60(9):1418–1424. doi:10.1212/01.WNL.0000066683.34093.E212743224
   PubMed Web of Science ®Google Scholar
• King JO, Mitchell PJ, Thomson KR, Tress BM. Cerebral venography and manometry in idiopathic intracranial hypertension. Neurology. 1995;45(12):2224–2228. doi:10.1212/WNL.45.12.22248848197
   PubMed Web of Science ®Google Scholar
• Elder BD, Rory Goodwin C, Kosztowski TA, et al. Venous sinus stenting is a valuable treatment for fulminant idiopathic intracranial hypertension. J Clin Neurosci. 2015;22:685–689. doi:10.1016/j.jocn.2014.10.01225579238
   PubMed Web of Science ®Google Scholar
• Davson H, Hollingsworth M, Segal MB. The mechanism and drainage of the cerebrospinal fluid. Brain. 1973;93:665–678. doi:10.1093/brain/93.4.665
   Google Scholar
• King JO, Mitchell PJ, Thompson KR, Tress BM. Manometry combined with cervical puncture in idiopathic intracranial hypertension. Neurology. 2002;58:26–30. doi:10.1212/WNL.58.1.2611781401
   PubMed Web of Science ®Google Scholar
• Rohr A, Dörner L, Stingele R, et al. Reversibility of venous sinus obstruction in idiopathic intracranial hypertension. Am J Neuroradiol. 2007;28(4):656–659.17416816
   PubMed Web of Science ®Google Scholar
• Buell TJ, Raper DMS, Pomeraniec IJ, et al. Transient resolution of venous sinus stenosis after high-volume lumbar puncture in a patient with idiopathic intracranial hypertension. J Neurosurg. 2018;129(1):153–156. doi:10.3171/2017.3.JNS16318128841117
   PubMed Web of Science ®Google Scholar
• Bono F, Giliberto C, Mastrandrea C, et al. Transverse sinus stenoses persist after normalization of the CSF pressure in IIH. Neurology. 2005;65(7):1090–1093. doi:10.1212/01.wnl.0000178889.63571.e516217064
   PubMed Web of Science ®Google Scholar
• Kelly LP, Saindane AM, Bruce BB, et al. Does bilateral transverse cerebral venous sinus stenosis exist in patients without increased intracranial pressure? Clin Neurol Neurosurg. 2013;115(8):1215–1219. doi:10.1016/j.clineuro.2012.11.00423219404
   PubMed Web of Science ®Google Scholar
• Stevens SA, Previte M, Lakin WD, et al. Idiopathic intracranial hypertension and transverse sinus stenosis: a modelling study. Math Med Biol. 2007;24:85–109. doi:10.1093/imammb/dql02517071863
   PubMed Web of Science ®Google Scholar
• Raper DMS, Ding D, Buell TJ, et al. Effect of body mass index on venous sinus pressures in idiopathic intracranial hypertension patients before and after endovascular stenting. Neurosurgery. 2018;82(4):555–561. doi:10.1093/neuros/nyx18628431144
   PubMed Web of Science ®Google Scholar
• Anconina R, Zur D, Kesler A, et al. Creating normograms of dural sinuses in healthy persons using computer-assisted detection for analysis and comparison of cross-section dural sinuses in the brain. J Clin Neurosci. 2017;40:190–194. doi:10.1016/j.jocn.2017.02.00628286027
   PubMed Web of Science ®Google Scholar
• Boddu SR, Gobin P, Oliveira C, et al. Anatomic measurements of cerebral venous sinuses in idiopathic intracranial hypertension patients. PLoS One. 2018;13(6):e0196275. doi:10.1371/journal.pone.019627529856739
   PubMed Web of Science ®Google Scholar
• Karahalios DG, Rekate HL, Khayata MH, et al. Elevated intracranial venous pressure as a universal mechanism in pseudotumor cerebri of varying etiologies. Neurology. 1996;46:198–202. doi:10.1212/WNL.46.1.1988559374
   PubMed Web of Science ®Google Scholar
• West JL, Greeneway GP, Garner RM, et al. Correlation between angiographic stenosis and physiologic venous sinus outflow obstruction in idiopathic intracranial hypertension. J Neurointerv Surg. 2019;11(1):90–94. doi:10.1136/neurintsurg-2018-01400429858399
   PubMed Web of Science ®Google Scholar
• Esfahani DR, Stevenson M, Moss HE, et al. Quantitative magnetic resonance venography is correlated with intravenous pressures before and after venous sinus stenting. Neurosurgery. 2015;77:254–260. doi:10.1227/NEU.000000000000077125860429
   PubMed Web of Science ®Google Scholar
• Boddu SR, Gobin P, Oliveira C, et al. Contrast enhanced magnetic resonance venography in the follow-up evaluation of idiopathic intracranial hypertension patients with cerebral venous sinus stenting. Clin Imaging. 2018;50:330–335. doi:10.1016/j.clinimag.2018.04.01629754068
   PubMed Web of Science ®Google Scholar
• Smith KA, Peterson JC, Arnold PM, et al. A case series of dural venous sinus stenting in idiopathic intracranial hypertension: association of outcomes with optical coherence tomography. Int J Neurosci. 2017;127:145–153. doi:10.3109/00207454.2016.115296726863329
   PubMed Web of Science ®Google Scholar
• Saber H, Lewis W, Sadeghi M, et al. Stent survival and stent-adjacent stenosis rates following venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. Interv Neurol. 2018;7(6):490–500. doi:10.1159/00049057830410529
   PubMed Web of Science ®Google Scholar
• Satti SR, Leishangthem L, Chaudry MI. Meta-analysis of CSF diversion procedures and dural venous sinus stenting in the setting of medically refractory idiopathic intracranial hypertension. Am J Neuroradiol. 2015;36(10):1899–1904. doi:10.3174/ajnr.A437726251432
   PubMed Web of Science ®Google Scholar
• Dinkin MJ, Patsalides A. Venous sinus stenting for idiopathic intracranial hypertension: where are we now? Neurol Clin. 2017;35:59–81. doi:10.1016/j.ncl.2016.08.00627886896
   PubMed Web of Science ®Google Scholar
• Lai LT, Danesh-Meyer HV, Kaye AH. Visual outcomes and headache following interventions for idiopathic intracranial hypertension. J Clin Neurosci. 2014;21:1670–1678. doi:10.1016/j.jocn.2014.02.02524974193
   PubMed Web of Science ®Google Scholar
• Shazly TA, Jadhav AP, Aghaebrahim A, et al. Venous sinus stenting shortens the duration of medical therapy for increased intracranial pressure secondary to venous sinus stenosis. J Neurointerv Surg. 2018;10:310–314. doi:10.1136/neurintsurg-2017-01310328487359
   PubMed Web of Science ®Google Scholar
• Boddu SR, Gobin P, Oliveira C, Dinkin M, Patsalides A. Pressure variations in cerebral venous sinuses of idiopathic intracranial hypertension patients. J Vasc Interv Neurol. 2018;10(1):25–30.
   Google Scholar
• Banta JT, Farris BK. Pseudotumor cerebri and optic nerve sheath decompression. Ophthalmology. 2000;107:1907–1912. doi:10.1016/S0161-6420(00)00340-711013197
   PubMed Web of Science ®Google Scholar
• Uretsky S. Surgical interventions for idiopathic intracranial hypertension. Curr Opin Ophthalmol. 2009;20:451–455. doi:10.1097/ICU.0b013e3283313c1c19687737
   PubMed Web of Science ®Google Scholar
• Nicholson P, Brinjikji W, Radovanovic I, et al. Venous sinus stenting for idiopathic intracranial hypertension: a systematic review and meta-analysis. J Neurointerv Surg. 2018. doi:10.1136/neurintsurg-2018-014172
   Web of Science ®Google Scholar
• Li K, Ren M, Meng R, Wang F, Ji X. Dural arteriovenous fistula formation complicated cerebral venous sinus stenosis after venous sinus stenting. World Neurosurg. 2018;120:400–402. doi:10.1016/j.wneu.2018.08.23030205216
   PubMed Web of Science ®Google Scholar
• Buell TJ, Raper DM, Ding D, et al. Development of an intracranial dural arteriovenous fistula after venous sinus stenting for idiopathic intracranial hypertension. J Neurointerv Surg. 2018;10(7):e15. doi:10.1136/neurintsurg-2017-013282.rep29563208
   PubMed Web of Science ®Google Scholar
• Coffman SA, Singh J, Wolfe S, Fargen KM. Unexpected occlusion of the contralateral transverse sinus after stenting for idiopathic intracranial hypertension. Interv Neuroradiol. 2018;24(6):718–721. doi:10.1177/159101991878716129976107
   PubMed Web of Science ®Google Scholar
• Lavoie P, Audet MÈ, Gariepy JL, et al. Severe cerebellar hemorrhage following transverse sinus stenting for idiopathic intracranial hypertension. Interv Neuroradiol. 2018;24(1):100–105. doi:10.1177/159101991773438928992723
   PubMed Web of Science ®Google Scholar
• Boddu SR, Gobin P, Dinkin M, et al. Impaired drainage of vein of Labbé following venous sinus stenting for idiopathic intracranial hypertension. J Neurointerv Surg. 2018;11:1–7.
   Web of Science ®Google Scholar
• Raper D, Buell TJ, Ding D, et al. Pattern of pressure gradient alterations after venous sinus stenting for idiopathic intracranial hypertension predicts stent-adjacent stenosis: a proposed classification system. J Neurointerv Surg. 2018;10(4):391–395. doi:10.1136/neurintsurg-2017-01313528637822
   PubMed Web of Science ®Google Scholar
• El Mekabaty A, Obuchowski NA, Luciano MG, et al. Predictors for venous sinus stent retreatment in patients with idiopathic intracranial hypertension. J Neurointerv Surg. 2017;9(12):1228–1232.27965382
   PubMed Web of Science ®Google Scholar
• Kumpe DA, Seinfeld J, Huang X, et al. Dural sinus stenting for idiopathic intracranial hypertension: factors associated with hemodynamic failure and management with extended stenting. J Neurointerv Surg. 2016;9:867–874. doi:10.1136/neurintsurg-2016-01281027935482
   PubMed Web of Science ®Google Scholar
• Goodwin CR, Elder BD, Ward A, et al. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients. Clin Neurol Neurosurg. 2014;127:75–78. doi:10.1016/j.clineuro.2014.09.01525459247
   PubMed Web of Science ®Google Scholar
• Mitchell J, Mollan SP, Vivek V, Sinclair AJ. Novel advances in monitoring and therapeutic approaches in IIH. Curr Opin Neurol. 2019;32(3):422–443. doi:10.1097/WCO.000000000000069030865008
   PubMed Web of Science ®Google Scholar
• Chandran A, Pulhorn H, McMahon C. Idiopathic intracranial hypertension VISION (Venous intervention versus shunting in IIH for optic nerve swelling) trial: patient perspective questionnaire. Br J Neurosurg. 2017;21:1–5.
   Google Scholar
• Patsalides A, Oliveira C, Wilcox J, et al. Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension. J Neurointerv Surg. 2018. doi:10.1136/neurintsurg-2018-014032
   Web of Science ®Google Scholar